Six-Step Lysergic Acid Derivative Synthesis Through Cyclization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for synthesizing lysergic acid and its derivatives are inefficient, lengthy, and generate significant waste, limiting the production of diverse analogs with therapeutic potential for neurodegenerative diseases and psychological disorders.
Innovation Solution
A method involving the coupling, dearomatization, and cyclization of halopyridine with a 4-haloindole derivative from simple aromatic precursors, followed by annulation and protecting group removal, to synthesize lysergic acid derivatives in six total steps, allowing for the development of novel compounds with therapeutic indices.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If existing methods for synthesizing lysergic acid are used, then the synthesis can be performed, but the number of steps is extensive and the methods are not reproducible
Solution Approach 1:
The synthesis method is divided into distinct functional stages: (1) formation of the indole core from halopyridine and 4-haloindole derivative, (2) dearomatization step, (3) cyclization to form the ergoline framework, and (4) protecting group removal. This segmentation allows each step to be optimized independently and improves overall reproducibility and efficiency.
Solution Approach 2:
The method employs preliminary formation of reactive intermediates and pre-arranged functional groups that facilitate subsequent cyclization steps. The coupling step预先 establishes the carbon framework, and protecting groups are strategically installed beforehand to enable clean cyclization and deprotection sequences.
2Productivity
If existing synthesis methods are implemented, then lysergic acid can be produced, but significant waste is generated
Solution Approach 1:
The method recovers and reuses reagents and intermediates that would otherwise be discarded. The coupling reaction uses commercially available halopyridine and 4-haloindole derivative, and the protecting groups are selectively removed to recover valuable intermediates for further synthesis or purification, minimizing waste generation.
Solution Approach 2:
The synthesis employs optimized reaction parameters including specific base choices, temperature control, and catalyst selection that improve atom economy and reduce byproducts. The dearomatization and cyclization steps are conducted under conditions that maximize yield while minimizing waste.
3Reliability
If existing methods are used, then synthesis is possible, but the methods are not reproducible and efficiency is limited
Solution Approach 1:
The method incorporates monitoring steps and characterization techniques that provide feedback on reaction progress and product purity. This allows for real-time adjustment of conditions to ensure reproducibility across different laboratories and scales, while maintaining high efficiency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method provides a practical and efficient synthesis of lysergic acid derivatives, enabling the production of non-natural analogs for treating neurodegenerative diseases, psychological, cognitive, and mood disorders, with the potential to pass through the blood-brain barrier.
Implementation Method 1
The method includes the coupling, dearomatization and cyclization of a halopyridine with a 4-haloindole derivative
Implementation Method 2
The method includes the coupling, dearomatization and cyclization of a halopyridine with a 4-haloindole derivative
Implementation Method 3
The method includes the coupling, dearomatization and cyclization of a halopyridine with a 4-haloindole derivative
Implementation Method 4
contacting the annulated compound and an agent effective to remove the protecting group
Data Source
AI summary
Methods of preparation of lysergic acid and derivatives thereof. Methods of using lysergic acid and derivatives thereof, such as methods of treating neurodegenerative disorders. Derivatives of lysergic acid and pharmaceutically acceptable salts thereof.